Eiermann M, Wrigley-Field E, Feigenbaum J, Helgertz J, Hernandez E, Boen C
Demography. 2022; 59(5):1953-1979.
PMID: 36124998
PMC: 9714293.
DOI: 10.1215/00703370-10235825.
Berche P
Presse Med. 2022; 51(3):104111.
PMID: 35124103
PMC: 8813723.
DOI: 10.1016/j.lpm.2022.104111.
Kessler S, Harder T, Schwemmle M, Ciminski K
Viruses. 2021; 13(11).
PMID: 34835056
PMC: 8624301.
DOI: 10.3390/v13112250.
Dronina J, Samukaite-Bubniene U, Ramanavicius A
J Nanobiotechnology. 2021; 19(1):348.
PMID: 34717656
PMC: 8556785.
DOI: 10.1186/s12951-021-01081-2.
Dostalik P, Krafcikova P, Silhan J, Kozic J, Chalupska D, Chalupsky K
J Virol. 2021; 95(15):e0046321.
PMID: 34011548
PMC: 8274614.
DOI: 10.1128/JVI.00463-21.
Lessons From Influenza Pandemics of the Last 100 Years.
Monto A, Fukuda K
Clin Infect Dis. 2019; 70(5):951-957.
PMID: 31420670
PMC: 7314237.
DOI: 10.1093/cid/ciz803.
The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses.
Linster M, Schrauwen E, van der Vliet S, Burke D, Lexmond P, Bestebroer T
J Virol. 2019; 93(8).
PMID: 30700609
PMC: 6450109.
DOI: 10.1128/JVI.01907-18.
Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.
Babu T, Perera R, Wu J, Fitzgerald T, Nolan C, Cowling B
J Infect Dis. 2018; 218(7):1054-1060.
PMID: 29762672
PMC: 6107991.
DOI: 10.1093/infdis/jiy291.
The Doctrine of Original Antigenic Sin: Separating Good From Evil.
Monto A, Malosh R, Petrie J, Martin E
J Infect Dis. 2017; 215(12):1782-1788.
PMID: 28398521
PMC: 5853211.
DOI: 10.1093/infdis/jix173.
Severe mortality impact of the 1957 influenza pandemic in Chile.
Chowell G, Simonsen L, Fuentes R, Flores J, Miller M, Viboud C
Influenza Other Respir Viruses. 2016; 11(3):230-239.
PMID: 27883281
PMC: 5410718.
DOI: 10.1111/irv.12439.
Global Mortality Impact of the 1957-1959 Influenza Pandemic.
Viboud C, Simonsen L, Fuentes R, Flores J, Miller M, Chowell G
J Infect Dis. 2016; 213(5):738-45.
PMID: 26908781
PMC: 4747626.
DOI: 10.1093/infdis/jiv534.
H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.
Isakova-Sivak I, Stukova M, Erofeeva M, Naykhin A, Donina S, Petukhova G
Hum Vaccin Immunother. 2015; 11(4):970-82.
PMID: 25831405
PMC: 4514355.
DOI: 10.1080/21645515.2015.1010859.
Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
Isakova-Sivak I, de Jonge J, Smolonogina T, Rekstin A, van Amerongen G, van Dijken H
PLoS One. 2014; 9(7):e102339.
PMID: 25058039
PMC: 4109939.
DOI: 10.1371/journal.pone.0102339.
Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus.
Worobey M, Han G, Rambaut A
Proc Natl Acad Sci U S A. 2014; 111(22):8107-12.
PMID: 24778238
PMC: 4050607.
DOI: 10.1073/pnas.1324197111.
Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
Lugner A, van Boven M, de Vries R, Postma M, Wallinga J
BMJ. 2012; 345:e4445.
PMID: 22791791
PMC: 3395306.
DOI: 10.1136/bmj.e4445.
Asian Influenza in New Haven, 1957-1958: An Epidemiological Survey.
Green R
Yale J Biol Med. 2011; 32(1):33-43.
PMID: 21434270
PMC: 2604039.
The epidemiology of pandemic A2 influenza in the Netherlands, 1957-58.
Mulder J, Masurel N
Bull World Health Organ. 2010; 22(3-4):399-407.
PMID: 20604069
PMC: 2555330.
Optimizing infectious disease interventions during an emerging epidemic.
Wallinga J, van Boven M, Lipsitch M
Proc Natl Acad Sci U S A. 2010; 107(2):923-8.
PMID: 20080777
PMC: 2818907.
DOI: 10.1073/pnas.0908491107.
Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957.
Liu J, Stevens D, Haire L, Walker P, Coombs P, Russell R
Proc Natl Acad Sci U S A. 2009; 106(40):17175-80.
PMID: 19805083
PMC: 2761367.
DOI: 10.1073/pnas.0906849106.
The Use of the Complement-Fixation Test in the Study and Diagnosis of Viral Diseases in Man and Animals-A Review: Part VIII. The Myxoviruses.
Rice C
Can J Comp Med Vet Sci. 1961; 25(6):151-6.
PMID: 17649306
PMC: 1583224.
